|
- 2018
“培土生金法”早期干预改善支气管哮喘模型幼鼠气道炎症反应的机制
|
Abstract:
摘要 目的:通过动物实验,研究“培土生金法”的代表方剂—异功散早期干预对支气管哮喘模型幼年小鼠气道炎症反应的作用,探索中医药防治儿童哮喘的药理机制.方法: 60只7 d龄BALB/c雌性幼鼠,随机分为正常对照组、模型对照组、益生菌(常乐康)组和异功散高、中、低剂量组,以卵蛋白致敏激发法成功制备哮喘幼鼠模型后,观察各组幼鼠的一般行为活动,并用HE染色法观察肺组织病理学改变,酶联免疫法(Elisa)测定肺泡灌洗液(bronchial alveolar lavage fluid,BALF)中白细胞介素10(interleukin 10,IL-10)、转化生长因子-β1(transforming growth factor-beta1,TGF-β1)和白细胞介素17(interleukin 17,IL-17)的变化.结果: 与益生菌类似,异功散高、中、低剂量组的炎症细胞浸润、组织损伤、水肿、上皮细胞脱落程度等,较模型对照组依次减轻,Underwood评分均显著低于模型对照组(P<0.01).益生菌组及异功散高、中、低剂量组BALF中的IL-10含量均显著高于模型对照组(P<0.01,P<0.05);益生菌组与异功散高、中、低剂量组BALF中的TGF-β1含量均高于模型对照组,其中益生菌组与异功散高、低剂量组有统计学差异(P<0.01,P<0.05);益生菌组与异功散高、中、低剂量组BALF中的IL-17含量均低于模型对照组,但均无统计学差异(P>0.05)结论: 异功散的早期干预,改善了支气管哮喘模型幼鼠的气道炎症反应,并影响了肺泡灌洗液中相关细胞因子如IL-10的含量.
[1] | RAISSY H H, KELLY H W.Benefits and risks of long-term asthma management in children: where are we heading?[J]. Drug Saf, 2017,40(3):201-210. |
[2] | 魏伟. 实验药理方法学[M].第4版.北京:人民卫生出版社,2010:1698. |
[3] | WEI W.Experimental Methodology of Pharmacology[M]. 4th ed. Beijing: People's Medical Publishing House,2010:1698. |
[4] | WANG M M.Professor WANG Shou-chuan's experience in treating pediatric lung system diseases[J].China Journal of Traditional Chinese Medicine and Pharmacy,2011,26(11):2602-2604. |
[5] | 谭惠元. 吴曙粤教授治疗小儿哮喘的经验介绍[J].广西中医药,2015,38(3):42-43. |
[6] | de ROOCK S,van ELK M,van DIJK M E,et al. Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans[J].Clin Exp Allergy, 2010,40(1):103-110 |
[7] | 刘梦昀,郑跃杰,黄建琼,等.婴儿型双歧杆菌对哮喘小鼠气道炎症的作用研究[J].中国微生态学杂志,2015,27(8):881-885. |
[8] | LIU M Y,ZHENG Y J,HUANG J,Q,et al.The effects of
<italic></italic>Bifidobacterium in fantis on the airway in flammation in murine models of asthma[J].Chinese Journal of Microecology,2015,27(8):881-885. |
[9] | ABRAMS E M, SZEFLER S J, BECKER A B.Does inhaled steroid therapy help emerging asthma in early childhood?[J]. The Lancet Respiratory Medicine,2017,5(10):827-834. |
[10] | UNDERWOOD S, FOSTER M, RAEBURN D.Time-curse of antigen-induced airway inflammation in the Guinea pig and its relationship to airway hyperresponsiveness[J]. Eur Rrespir J, 1995,8(12):2104-2113 |
[11] | 王明明. 汪受传教授治疗小儿肺系疾病经验[J].中华中医药杂志,2011,26(11):2602-2604. |
[12] | 覃雪军,银维谋,谭毅.调节性T淋巴细胞与Th17细胞在哮喘气道炎症中的作用[J].中国临床新医学,2015,8(10):996-1000. |
[13] | QIN X J,YIN W M,TAN Y.Treg/Th17 Paradigm in asthmatic airway inflammation[J].Chinese Journal of New Clinical Medicine,2015,8(10):996-1000. |
[14] | NOVAL RIVAS M, CHATILA T A.Regulatory T cells in allergic diseases[J]. J Allergy Clin Immunol, 2016,138(3):639-652. |
[15] | QU C X, ZHANG Z K.Current views of pediatric asthma[J]. Eur Rev Med Pharmacol Sci, 2017,21(4 Suppl):106-108. |
[16] | TAN H Y.Professor Wu Shuyue's experience in treating childhood asthma[J].Guangxi Journal of Traditional Chinese Medicine,2015,38(3):42-43. |
[17] | MCLOUGHLIN R M,MILLS K H.Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma[J]. J Allergy Clin Immunol,2011,127(5):1097-1107. |
[18] | COSMI L, LIOTTA F, ANNUNZIATO F.Th17 regulating lower airway disease[J]. Curr Opin Allergy Clin Immunol, 2016,16(1):1-6. |
[19] | KONIECZNA P,GROEGER D,ZIEGLER M,et al.Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells[J].Gut,2012,61(3):354-366. |